CereMetrix Corp. Introduces Enhancements to its Advanced Medical Imaging and Analytics Platform
CereMetrix 2.0 leverages the platform’s quantitative SPECT imaging and reporting capabilities to accommodate a broader range of modality agnostic clinical and research applications. Read Press Release
CereHealth Corporation Granted Patent for Composite Average and Clustering Technique
CereHealth Corporation has been granted a 3rd patent on its novel medical imaging and data analytics technology. Read Press Release
CereHealth Welcomes New Members to its Scientific and Medical Advisory Board
CereHealth has assembled an expert team of business, scientific and medical advisors in pursuit of worldwide market penetration for its browser-based, cloud-enabled imaging and data analytics platforms, as it welcomes Drs. James Chomas and Ty Vachon. Read Press Release
Going against the norm: validation of a novel alternative to brain SPECT normative datasets
A New Frontier for Medicine: CereHealth’s validation of their novel alternative to brain SPECT quantification We invited a noted Radiologist, Dr. Cyrus Raji, to work with our Senior Medical Imaging Engineer, Lindsay Quandt, to explore our unique methodology and how it compares to use of normative datasets. Their analysis and findings are now available online […]
AD’s Heterogeneous Nature
AD’s Heterogeneous Nature John Kelley, Chairman and CEO of CereHealth Corp, was a featured speaker at a Digital Pathology & Precision Medicine Symposium on September 4, 2020, which was hosted by Dr. Rhoda Au, Professor of Anatomy & Neurobiology, Neurology, and Epidemiology at Boston University’s School of Medicine. The conference was organized by Oxford Global […]
From Football to Healthcare, Data Analytics Leaves No Industry Left Behind
After months of speculation by players, fans and pundits, the long-awaited NFL draft has arrived. Questions like which ill-fated quarterback will go to the Browns are intriguing, but even more fascinating is the ‘Moneyball’ approach that team analysts are using to evaluate players. The best picks may no longer be decided in the film room, […]
FDA Clears CereMetrix®’s Neuroimaging Analytics and Clinical Workflow Platform
CereMetrix Silver will feature advanced neuroimaging capabilities that automatically pinpoints and quantifies brain function down to the voxel level. DENVER, COLORADO, March 13, 2018 – CereMetrix®, a subsidiary of CereHealth Corp., has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its neuroimaging analytics and quantification platform CereMetrix Silver. Providers will now have access to […]
